DOI: 10.1055/s-00000069

Seminars in Liver Disease

Referenz


Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC).
Available at:
http://clinicaltrials.gov/ct2/show/NCT01015833 . Accessed January 11, 2012

Bibliographische Angaben herunterladen

Suchen in: